IgG4 Syndrome: Old Disease, New Perspective

REFERENCES

1. 1.↵
   1. Littman BH,
   2. Di Mario L,
   3. Plebani M,
   4. Marincola FM

   . What’s next in translational medicine? Clin Sci Lond 2007;112:217–27.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Masaki Y,
   2. Dong L,
   3. Kurose N,
   4. Kitagawa K,
   5. Morikawa Y,
   6. Yamamoto M,
   7. et al.

   Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009;68:1310–5.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Yamamoto M,
   2. Harada S,
   3. Ohara M,
   4. Suzuki C,
   5. Naishiro Y,
   6. Yamamoto H,
   7. et al.

   Clinical and pathological differences between Mikulicz’s disease and Sjogren’s syndrome. Rheumatology 2005;44:227–34.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Yamamoto M,
   2. Takahashi H,
   3. Ohara M,
   4. Suzuki C,
   5. Naishiro Y,
   6. Yamamoto H,
   7. et al.

   A new conceptualization for Mikulicz’s disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006;16:335–40.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Kamisawa T,
   2. Okamoto A

   . IgG4-related sclerosing disease. World J Gastroenterol 2008;14:3948–55.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Vitali C,
   2. Bombardieri S,
   3. Jonsson R,
   4. Moutsopoulos HM,
   5. Alexander EL,
   6. Carsons SE,
   7. et al.

   Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–8.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Khosroshahi A,
   2. Bloch DB,
   3. Deshpande V,
   4. Stone JH

   . Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 2010 Feb 26. E-pub ahead of print.
8. 8.↵
   1. Masaki Y,
   2. Sugai S,
   3. Umehara H

   . IgG4-related diseases including Mikulicz’s disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol 2010;37:1380–5.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Bateman AC,
   2. Deheragoda MG

   . IgG4-related systemic sclerosing disease — an emerging and under-diagnosed condition. Histopathology 2009;55:373–83.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Zen Y,
    2. Fujii T,
    3. Harada K,
    4. Kawano M,
    5. Yamada K,
    6. Takahira M,
    7. et al.

    Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007;45:1538–46.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Miyoshi H,
    2. Uchida K,
    3. Taniguchi T,
    4. Yazumi S,
    5. Matsushita M,
    6. Takaoka M,
    7. et al.

    Circulating naive and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Pancreas 2008;36:133–40.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Jeannin P,
    2. Delneste Y,
    3. Lecoanet-Henchoz S,
    4. Gretener D,
    5. Bonnefoy JY

    . Interleukin-7 (IL-7) enhances class switching to IgE and IgG4 in the presence of T cells via IL-9 and sCD23. Blood 1998;91:1355–61.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Ishida F,
    2. Kitano K,
    3. Kobayashi H,
    4. Saito H,
    5. Kiyosawa K

    . Elevated IgG4 levels in a case with multicentric Castleman’s disease. Br J Haematol 1997;99:981–2.

    OpenUrlPubMed
14. 14.↵
    1. Holland M,
    2. Hewins P,
    3. Goodall M,
    4. Adu D,
    5. Jefferis R,
    6. Savage CO

    . Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener’s granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol 2004;138:183–92.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Futei Y,
    2. Amagai M,
    3. Ishii K,
    4. Kuroda-Kinoshita K,
    5. Ohya K,
    6. Nishikawa T

    . Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. J Dermatol Sci 2001;26:55–61.

    OpenUrlCrossRefPubMed